Literature DB >> 10797356

Early deaths in childhood cancer.

M R Hamre1, J Williams, P Chuba, K Bhambhani, Y Ravindranath, R K Severson.   

Abstract

BACKGROUND: Deaths prior to or shortly after the diagnosis of childhood cancer may reflect inadequacies in detection and appropriate referral for care. This study was performed to determine the extent of and factors associated with early death in childhood cancer. PROCEDURE: Patients with of primary cancer, aged <20 years at diagnosis, were identified from the SEER data (n = 23,470) from 1973 to 1995. Early deaths were defined as cases identified by 1) death certificate, 2) autopsy report, or 3) death within 1 month of initial diagnoses (n = 481). Cause of death was determined by ICD-8 and -9 codes. Age at diagnosis, year of diagnosis, morphology, site of disease, race, and gender were evaluated for association with early death.
RESULTS: Age <1 year at diagnosis (6.2% early deaths), being diagnosed earlier in the observation period, and a diagnosis of a brain tumor, neuroblastoma, leukemia, or liver tumor were associated with increased early death. Gender and race were not associated with early death. Among the cases for whom the malignant diagnosis was made at the time of death (n = 119), the cause of death was nonmalignant for 36. For 22 of these cases the malignancy was an incidental finding and appeared not to contribute directly to the cause of death. Among these patients, 11 had neuroblastoma, 9 being <1 year of age.
CONCLUSIONS: A decrease in the proportion of early deaths associated with childhood cancer has occurred during the past 2 decades. This decrease may reflect earlier diagnosis or improved imaging capabilities, surgical techniques, medical therapy, and supportive care. Awareness among pediatricians, general practitioners, and emergency physicians is warranted, with a focus on high-risk groups for early detection among childhood cancer patients. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797356     DOI: 10.1002/(sici)1096-911x(200005)34:5<343::aid-mpo5>3.0.co;2-b

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  8 in total

1.  Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study.

Authors:  Jean-François Brasme; Martin Chalumeau; François Doz; Brigitte Lacour; Dominique Valteau-Couanet; Stephan Gaillard; Olivier Delalande; Nozar Aghakhani; Christian Sainte-Rose; Stéphanie Puget; Jacques Grill
Journal:  Eur J Pediatr       Date:  2011-05-03       Impact factor: 3.183

2.  Sudden death due to adrenal neuroblastoma: child abuse mimic?

Authors:  Ko Un Park; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2010-09-21       Impact factor: 2.007

3.  Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem.

Authors:  Adam L Green; Elissa Furutani; Karina Braga Ribeiro; Carlos Rodriguez Galindo
Journal:  J Clin Oncol       Date:  2017-03-06       Impact factor: 44.544

4.  Pediatric cancer knowledge: assessment of knowledge of warning signs and symptoms for pediatric cancer among Brazilian community health workers.

Authors:  Gloria M Workman; Raul C Ribeiro; Shesh N Rai; Arli Pedrosa; Don E Workman; Francisco Pedrosa
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

5.  Early deaths from childhood cancer. A report from the Childhood Cancer Registry of Piedmont, Italy, 1967-1998.

Authors:  Guido Pastore; Silvia Viscomi; Maria Luisa Mosso; Milena Maria Maule; Benedetto Terracini; Corrado Magnani; Franco Merletti
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

6.  Hospitalization and mortality outcomes in the first 5 years after a childhood cancer diagnosis: a population-based study.

Authors:  Angela Steineck; Eric J Chow; David R Doody; Beth A Mueller
Journal:  Cancer Causes Control       Date:  2021-04-09       Impact factor: 2.532

7.  Early death in pediatric cancer: remaining questions and next steps.

Authors:  Elissa Furutani; Carlos Rodriguez-Galindo; Adam L Green
Journal:  Oncotarget       Date:  2017-11-01

Review 8.  Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.

Authors:  A Laura Nijstad; Shelby Barnett; Arief Lalmohamed; Inez M Bérénos; Elizabeth Parke; Vickyanne Carruthers; Deborah A Tweddle; Jordon Kong; C Michel Zwaan; Alwin D R Huitema; Gareth J Veal
Journal:  Eur J Cancer       Date:  2021-12-02       Impact factor: 9.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.